ALEMBIC
Back to Balance Sheet
|
ALEMBIC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹54 Cr | ₹53 Cr | ₹43 Cr | ₹68 Cr | ₹53 Cr |
What is the latest Total Non-Current Liabilities ratio of ALEMBIC ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹54 Cr |
| Mar2024 | ₹53 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹68 Cr |
| Mar2021 | ₹53 Cr |
How is Total Non-Current Liabilities of ALEMBIC Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹54 Cr | 1.98 | |
| Mar2024 | ₹53 Cr | 23.76 | |
| Mar2023 | ₹43 Cr | -36.78 | |
| Mar2022 | ₹68 Cr | 28.72 | |
| Mar2021 | ₹53 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALEMBIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC | ₹1,821.0 Cr | -5.7% | -23% | -26% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,647.0 Cr | 0.1% | -0.4% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹157,862.0 Cr | -1.1% | -7.1% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,846.0 Cr | 0.2% | -4.5% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,720.0 Cr | 0.2% | -4% | 6% | Stock Analytics | |
| CIPLA | ₹98,795.9 Cr | 0% | -9.1% | -18.5% | Stock Analytics | |
ALEMBIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | -5.7% |
-23% |
-26% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses